{"id":454,"count":1,"description":"<style>\r\n  .ncord-wrap { display: grid; grid-template-columns: 5rem 1fr; row-gap: 0.75rem; column-gap: 0.5rem; }\r\n  .ncord-title { grid-column: 1 \/ -1; font-weight: 600; font-size: 1.05rem; margin-bottom: 0.25rem; }\r\n  .ncord-code { font-weight: 600; white-space: nowrap; }\r\n  .ncord-text { line-height: 1.5; }\r\n\r\n  \/* ensure bullets appear even if the theme globally hides them *\/\r\n  .ncord-text ul { list-style: disc !important; list-style-position: outside; padding-left: 1.25rem; margin: .5rem 0 .25rem 0; }\r\n  .ncord-text li { display: list-item !important; list-style: inherit !important; }\r\n<\/style>\r\n\r\n<div class=\"ncord-wrap\">\r\n  <div class=\"ncord-title\">Neonatal Cord Blood Testing (Neonatal Cord Statements)<\/div>\r\n\r\n  <div class=\"ncord-code\">N1<\/div>\r\n  <div class=\"ncord-text\">Samples for pre-transfusion testing in the neonate must be collected and labeled in compliance with requirements of the Canadian standards for blood and blood components (CAN\/CSA Z902).<\/div>\r\n\r\n  <div class=\"ncord-code\">N2<\/div>\r\n  <div class=\"ncord-text\">\r\n    Cord blood sample collection and testing is recommended for all neonates when:\r\n    <ul>\r\n      <li>the pregnant person is RhD negative, RhD indeterminate or RhD unknown; or<\/li>\r\n      <li>the pregnant person has a clinically significant antibody;<\/li>\r\n      <li>there is a history of HDFN-mediated hyperbilirubinemia requiring transfusion (intrauterine or postnatal) or IVIG therapy for a prior fetus or neonate;<\/li>\r\n      <li>there are known risk factors for nonimmune neonatal jaundice or anemia (such as G6PD deficiency).<\/li>\r\n    <\/ul>\r\n  <\/div>\r\n\r\n  <div class=\"ncord-code\">N3<\/div>\r\n  <div class=\"ncord-text\">Neonatal RhD typing on a cord or peripheral blood sample is required for all RhD negative or indeterminate pregnancies.<\/div>\r\n\r\n  <div class=\"ncord-code\">N4<\/div>\r\n  <div class=\"ncord-text\">A weak D test is required on a cord or neonatal peripheral sample when the mother and neonate are RhD negative or indeterminate.<\/div>\r\n\r\n  <div class=\"ncord-code\">N5<\/div>\r\n  <div class=\"ncord-text\">For alloimmunized pregnancies, cord phenotyping for the implicated antigen and DAT are recommended.<\/div>\r\n\r\n  <div class=\"ncord-code\">N6<\/div>\r\n  <div class=\"ncord-text\">For neonates with hyperbilirubinemia, investigations and management according to the Guidelines of the Canadian Paediatric Society are recommended.<\/div>\r\n\r\n  <div class=\"ncord-code\">N7<\/div>\r\n  <div class=\"ncord-text\">A neonatal DAT is not recommended as a single test to screen for an alloimmune cause of hyperbilirubinemia.<\/div>\r\n\r\n  <div class=\"ncord-code\">N8<\/div>\r\n  <div class=\"ncord-text\">If neonatal transfusion is required, a neonatal peripheral blood or maternal blood sample should be used for antibody screen.<\/div>\r\n<\/div>\r\n","link":"https:\/\/transfusionontario.org\/en\/category\/perinatal\/neonatal-cord-testings\/","name":"Neonatal Cord Blood Testing","slug":"neonatal-cord-testings","taxonomy":"category","parent":448,"meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/categories\/454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/categories"}],"about":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/taxonomies\/category"}],"up":[{"embeddable":true,"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/categories\/448"}],"wp:post_type":[{"href":"https:\/\/transfusionontario.org\/en\/wp-json\/wp\/v2\/posts?categories=454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}